GHK-Cu
A naturally occurring tripeptide complexed with copper that stimulates collagen synthesis and wound healing with 30+ years of clinical research.
Also known as: Copper Peptide, Glycine-Histidine-Lysine Copper Complex
Available on Forge Amino
GHK-Cu 50MG — independently lab tested, 99%+ purity, QR-linked COA.
Important: This content is for informational and research purposes only and is not intended for human or veterinary use. Consult your physician for health-related guidance and laboratory monitoring.
How It Works
Upregulates lysyl oxidase and lysyl hydroxylase, enzymes critical for collagen cross-linking and stability. Modulates gene expression to increase type I and III collagen synthesis while downregulating inflammatory pathways.
Key Benefits
- ✓70% increase in collagen production
- ✓Improved skin elasticity and thickness
- ✓Wrinkle reduction and fine-line improvement
- ✓Enhanced wound healing
- ✓Anti-inflammatory gene modulation
Dosing Protocols
Beginner / Intermediate
Dose
1 mg
Frequency
Once daily subcutaneous
Cycle Length
4-8 weeks
Notes
Reconstitute 50 mg vial with 2-3 ml BAC water; topical also effective for skin
Advanced
Dose
2 mg
Frequency
Once daily subcutaneous
Cycle Length
8-12 weeks
Notes
Higher doses support comprehensive collagen remodeling
Side Effects & Safety
Common Side Effects
- Minimal; topical non-irritating
- Rare injection site reactions
- No systemic toxicity reported
Contraindications
- Wilson's disease (copper metabolism disorder)
- Metal allergy or hypersensitivity
- Pregnancy and lactation (systemic use)
Stacking & Synergies
These compounds have complementary mechanisms and may enhance results when used together.
Key Takeaway
Rebuild from inside out: GHK-Cu triggers collagen synthesis for visibly rejuvenated skin and stronger tissues.
Research Disclaimer: This content is for informational and research purposes only. It is not medical advice. These products are not approved by the FDA for human consumption. Consult a qualified healthcare provider before starting any new protocol. The information provided is based on preclinical research and anecdotal reports and has not been formally evaluated in randomized controlled trials.